Products Specications
| Products | Specification | Volume of vials | Packing form |
| Cefuroxime Sodium for inection | CP;USP | 7ml mould vial | 50vials/box |
| 10vials/box | |||
| 1vials/box | |||
| (1vial+1 solvent)/box | |||
| 10ml mould vial | 50vials/box | ||
| 10vials/box | |||
| 1vials/box | |||
| (1vial+1 solvent)/box | |||
| 12ml mould vial | 50vials/box | ||
| 10vials/box | |||
| 1vials/box | |||
| (1vial+1 solvent)/box | |||
| 15ml mould vial | 50vials/box | ||
| 10vials/box | |||
| 1vials/box | |||
| (1vial+1 solvent)/box |
Composition of Cefuroxime Sodium for inection:
Each vial contains: Cefuroxime Sodium USP equivalent to 750mg or 1.5g Cefuroxime.



Pharmacological Action
Cefuroxime is a bactericidal semi-synthetic cephalosporin antibiotic which is resistant to most ß-lactamases and is active against a wide range of Gram-positive and Gram-negative organisms. Peak serum levels of cefuroxime are reached within 30 ~45 minutes after intramuscular administration. The serum half-life after either intramuscular or intravenous injection is about 70 minutes. Concurrent administration of probenecid produces an elevated peak serum level and restricts the excretion of the antibiotic. There is almost complete recovery of unchanged cefuroxime in the urine within 24 hours of administration the major part being eliminated within the first 6 hours. The tubular excretion component of renal clearance of cefuroxime is of the order of 50%.
Indications of Cefuroxime Sodium for inection
It is indicated that Cefuroxime sodium for injection is for the treatment of the following infections when caused by susceptible strains of the designated micro-organisms:
Respiratory tract infections
Ear, nose and throat infections
Urinary tract infections
Bone and joint infections
Soft tissue infections
Obstetrics and gynaecological infections
Gonorrhoea
Prophylaxis against infection in abdominal, cardiac and pulmonary surgery where there is an increased risk of infection.
Bacteriology of Cefuroxime Sodium for inection

Sensitivity tests should be carried out for wherever possible. Cefuroxime is active in vitro against:
Staphylococcus aureus including penicillin-resistant strains but not the rare methicillin-resistant strains
Escherichia coli
Klebsiella spp
Enterobacter spp
Streptococcus pyogenes
Streptococcus viridans
Clostridium spp
Proteus mirabilis
Proteus rettgeri
Proteus vulgaris
Proteus morganii
Neisseria spp - including ß-lactamase producing strains of N. gonorrhoea
Haemophilus influenzae
Bacteroides fragilis
In vitro sensitivity does not necessarily imply in vivo efficacy.



Contra-indications of Cefuroxime Sodium for inection
Cefuroxime is contra-indicated in patients with a known hyper-sensitivity to cephalosporins.
The safety in pregnancy and lactation has not been established.
Hot Tags: cefuroxime sodium for injection, China cefuroxime sodium for injection manufacturers, suppliers, factory, penicillin solid preparations, Ceftazidime For Injection, Oxacillin Sodium For Injection, cephalosporin powder injection, Procaine Penicillin For Injection








